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We report a case of neonatal-onset autoinflammatory
syndrome that resembles Nakajo-Nishimura syndrome
(NNS), a rare autoinflammatory syndrome caused by a
homozygous PSMB8 mutation. The patient is a 7-year-
old boy who demonstrated clinical findings that differ
from those of typical NNS.
Exudative erythemas on his face, trunk, and extremi-
ties developed 2 weeks after birth. At 1 month of age,
the patient developed fever, elevated serum C-reactive
protein levels, and elevated hepatic amino transferase
levels. A febrile convulsion caused basal ganglia calcifi-
cation at 4 months of age. Severe pulmonary arterial
hypertension of unknown origin (NT-proBNP 33,445
pg/mL) was diagnosed at 7 months of age. These symp-
toms improved after administration of bozentan and
ambrisentan, which are endothelin receptor antagonists.
At 9 months of age, he developed heliotrope rash, ede-
matous erythema on his extremities, and myositis with
elevated serum creatine kinase levels (16,000 IU/L).
Antinuclear antibodies, as well as anti-Jo-1 and anti-
DNA antibodies, were negative. Skin and muscle biop-
sies revealed massive cellular inflammation, consisting
primarily of lymphocytes and monocytic cells, located in
the epidermis and between muscle fibers with fat tissue
necrosis in the subcutis. Concomitant degeneration and
regeneration of muscle fibers occurred and resulted in
moderate variations in the fiber size.
These results initially led to a diagnosis of juvenile
dermatomyositis. His symptoms temporarily improved
with corticosteroid treatment but recurred periodically.
Administration of systemic agents such as azathioprine,
methotrexate, cyclosporine, cyclophosphamide,
mycophenolate mofetil, and intravenous immunoglobu-
lins did not lead to remission.
Hepatosplenomegaly and liver cirrhosis due to pulmon-
ary arterial hypertension induced portal hypertension
beginning at age 6. The serum levels of interleukin (IL)-
1b (28 pg/mL), IL-6 (84.3 pg/mL), TNFa (21.6 pg/mL),
IL-18 (595 pg/mL), and IFN-g (7.0 IU/mL) were all
increased during the periodic recurrences. These periodic
symptoms were refractory to several immunosuppressive
agents, which suggested an autoinflammatory syndrome.
Although presence of fever, erythemas, basal ganglia cal-
cification and hepatosplenomegaly suggested NNS, some
of the characteristic symptoms of NNS, such as lipomus-
cular atrophy in the upper body and long clubbed fingers
with joint contractures, did not occur in this patient.
Since no significant mutations had been detected in
the NLRP3, NOD2, MEFV, MVK, TNFRSF1A, and
PSMB8 genes, whole exome sequencing of the patient
and his parents was performed and a novel de novo het-
erozygous mutation has been identified in PSMB9,
encoding the immunoproteasome subunit beta1i, in the
patient. Our case might represent a novel proteasome-
associated autoinflammatory syndrome similar to but
distinct from NNS, in which a heterozygous mutation of
the PSMB9 gene is responsible.
Written informated consent for publication of their
clinical details was obtained from the patient/parent/
guardian/relative of the patient.
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